---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-25-000097"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:31:34.565695+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lifecore Biomedical approves FY2026 bonus plan for executives with EBITDA, revenue targets

## Summary
- Board approved FY2026 cash bonus plan for CEO Paul Josephs (100% target), CFO Ryan Lake (60%), and CAO Thomas Salus (50%).
- Bonus weighted 80% to Adjusted EBITDA and development revenue; max payout 200% of target; no bonus if minimum EBITDA unmet.
- Individual performance goals and company business goals each weighted 10%.
- Salus receives 125% of any bonus earned per employment agreement; all bonuses subject to clawback policy.

## SEC filing metadata
- accession: 0001005286-25-000097
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000097/0001005286-25-000097-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000097/lndc-20250715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-25-000097
- JSON: https://secwatch.observer/filing/0001005286-25-000097.json
- Plain text: https://secwatch.observer/filing/0001005286-25-000097.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.